Human high-grade gliomas (hHGG) remain a therapeutic challenge in neuro-oncology despite
current multimodality treatments. We recently demonstrated that murine embryonic stem …

Recent clinical data shows that arsenic trioxide (As 2 O 3 ) causes remission in patients with
acute promyelocytic leukemia and multiple myeloma without severe side effects. Laboratory …

Background and Purpose Acute cerebral ischemia after subarachnoid hemorrhage (SAH) is
a major cause of morbidity whose precise etiology is unclear. The purpose of this study was …

✓ Meningiomas arising in the first two decades of life are uncommon and their characteristics
are controversial. Some authors believe meningiomas in younger patients occur in …

METHODS Databases from the American Association of Neurological Surgeons (AANS) and
the American Board of Neurological Surgery (ABNS) from 1964 to 2013 were reviewed for …

Objective Systematic review of the literature to evaluate the role of decompressive craniectomy
(DC) after severe traumatic brain injury (TBI), comparing the first major randomized …

Appropriate imaging modalities for the follow-up of malignant or aggressive musculoskeletal
tumors include radiography, MRI, CT, 18 F-2-fluoro-2-deoxy-D-glucose PET/CT, 99m Tc …

Arsenic trioxide (As 2 O 3) has shown considerable efficacy in treating hematological
malignancies with induction of programmed cell death (PCD) type I, apoptosis. However, the …

Preface The leadership of Women in Neurosurgery (WINS) has been asked by the Board of
Directors of the American Association of Neurological Surgeons (AANS) to compose a white …

Object. Ionizing radiation is the gold-standard adjuvant treatment for glioblastoma multiforme
(GBM), the most aggressive primary brain tumor. The mechanisms underlying neoplastic …